---
document_datetime: 2023-09-21 21:52:23
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/libmeldy-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: libmeldy-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 2.6952737
conversion_datetime: 2025-12-30 10:26:58.714734
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Libmeldy

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0011/G            | This was an application for a group of variations. B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation | 23/02/2023                          |                                             | SmPC, Annex II, Labelling and PL |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                          |            |     |          |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|-----------------------------------|
| IB/0013/G           | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 07/02/2023 | n/a |          |                                   |
| IB/0012/G           | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 12/01/2023 | n/a |          |                                   |
| PSUSA/10899 /202206 | Periodic Safety Update EU Single assessment - atidarsagene autotemcel                                                                                                                                                                                                                                                      | 12/01/2023 | n/a |          | PRAC Recommendation - maintenance |
| IB/0009             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                              | 26/08/2022 |     | Annex II |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10899 /202112   | Periodic Safety Update EU Single assessment - atidarsagene autotemcel                                                                                                                                                                                          | 07/07/2022   | n/a        |                        | PRAC Recommendation - maintenance   |
|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------------------------------|
| IAIN/0008/G           | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                    | 23/06/2022   |            | SmPC, Labelling and PL |                                     |
| PSUSA/10899 /202106   | Periodic Safety Update EU Single assessment - atidarsagene autotemcel                                                                                                                                                                                          | 13/01/2022   | n/a        |                        | PRAC Recommendation - maintenance   |
| II/0004               | B.I.b.1.g - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Widening of the approved specs for starting mat./intermediates, which may have a significant effect on the quality of the AS and/or the FP | 16/12/2021   | n/a        |                        |                                     |
| IB/0006               | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                  | 08/11/2021   | 27/01/2022 | Annex II               |                                     |
| IB/0003               | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                         | 07/06/2021   | n/a        |                        |                                     |
| IAIN/0002             | A.3 - Administrative change - Change in name of the AS or of an excipient                                                                                                                                                                                      | 23/04/2021   | 27/01/2022 | SmPC, Labelling and PL |                                     |

<div style=\"page-break-after: always\"></div>

| IAIN/0001/G   | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient   | 13/01/2021   | 27/01/2022   | SmPC, Annex II, Labelling and PL   |
|---------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|